OR WAIT null SECS
January 23, 2024
Acquisition is expected to strengthen company’s CDMO business, while establishing a footprint in the generics space.
January 10, 2024
Acquisition is expected to offer life sciences clients a boost in expertise and insight.
January 08, 2024
While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector.
January 03, 2024
How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.
December 21, 2023
In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
December 15, 2023
MoU aims to align the pharmaceutical and cold chain sectors by boosting operations.
December 13, 2023
Pfizer said that the addition of Seagen to its current operations could add more than $10 billion in risk-adjusted revenues by 2030.
December 06, 2023
While new forms of pharmacy continue to surface beyond brick-and-mortar retail, a look at what is driving this shift in perspective—and "pharmacies of the future"—is warranted.
November 28, 2023
The designation—which ranks the fastest-growing companies in North America—is powered by AeroSafe’s 477% growth rate.
November 20, 2023
Purchase grows the company’s CRYOPDP domestic footprint while strengthening working relationship between both parties.